Sitara Peroxide Ltd (SPL)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 27 Oct 2026
Key indicators
| Last close | PKR 49.37 |
|---|---|
| 52-week range | 17.80 – 132.22 |
| Return, 1 month / 3 months | +15.9% / −16.1% |
| Return, 1 year / 3 years | +153.2% / +163.6% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 77.4% |
| Worst drawdown (1 year) | -72.0% |
| Average daily value traded | 2.06M PKR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sitara Peroxide Limited is a Karachi-based chemical company that manufactures and sells hydrogen peroxide and a disinfectant product called Sitara Safe. Hydrogen peroxide is a versatile chemical used for bleaching, cleaning and disinfection across many industries, and it breaks down into water and oxygen after use. The company's disinfectant line serves customers who need hygienic cleaning and sanitising products.
The shares are listed on the Pakistan Stock Exchange (PSX) under the code SPL, and the price on this page is in Pakistani rupees (PKR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sitara Peroxide Ltd (SPL) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 49.37 on 27 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 493 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 153.2% and over the last three months it fell 16.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.0% | ||
| From 52-week high | -58.9% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -16.1% | ||
| 6-month return | -17.6% | ||
| 12-month return, skipping the last month | 118.5% | ||
| Stability (higher is calmer) | 6 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 77.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -72.0% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 2.06M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | +15.9% |
| 3 months | −16.1% |
| 6 months | −17.6% |
| 1 year | +153.2% |
| 3 years | +163.6% |
| 5 years | +117.5% |
Signals
| 50-day / 200-day average | 47.48 / 54.86 |
|---|---|
| Golden / death cross (60 days) | Death, 40 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.85 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.